5 reports of this reaction
5.7% of all LEVOTHYROXINE, LIOTHYRONINE reports
#1 most reported adverse reaction
PRODUCT SUBSTITUTION ISSUE is the #1 most commonly reported adverse reaction for LEVOTHYROXINE, LIOTHYRONINE, manufactured by Acella Pharmaceuticals, LLC. There are 5 FDA adverse event reports linking LEVOTHYROXINE, LIOTHYRONINE to PRODUCT SUBSTITUTION ISSUE. This represents approximately 5.7% of all 87 adverse event reports for this drug.
Patients taking LEVOTHYROXINE, LIOTHYRONINE who experience product substitution issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT SUBSTITUTION ISSUE is moderately reported among LEVOTHYROXINE, LIOTHYRONINE users, representing a notable but not dominant share of adverse events.
In addition to product substitution issue, the following adverse reactions have been reported for LEVOTHYROXINE, LIOTHYRONINE:
The following drugs have also been linked to product substitution issue in FDA adverse event reports:
PRODUCT SUBSTITUTION ISSUE has been reported as an adverse event in 5 FDA reports for LEVOTHYROXINE, LIOTHYRONINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT SUBSTITUTION ISSUE accounts for approximately 5.7% of all adverse event reports for LEVOTHYROXINE, LIOTHYRONINE, making it one of the most commonly reported side effect.
If you experience product substitution issue while taking LEVOTHYROXINE, LIOTHYRONINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.